Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Supporters often highlight the potential for significant therapeutic outcomes, especially in conditions where conventional medications have proven limited. However, this is to assess the significant financial expenditure associated with CPI stem cell t